|Conditional recommendation based on low-quality evidence; may consider switching to an IL-12/23i if the patient has severe psoriasis or contraindications to TNFi biologics, including congestive heart failure, previous serious infections, recurrent infections, or demyelinating disease, or if the patient prefers less frequent drug administration.| |
|10. Switch to a TNFi biologic over switching to another OSM (PICO 49)|Low (72, 73, 76, 83â€“85)|